InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
5
T+90 hit rate
29%
T+90 mean return
-7.1%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Clague Laura, Chief Financial Officer. Officer active across 4 companies, notably Travere Therapeutics, Inc.. Cumulatively, 18 filings have been recorded. Split: 0 buy · 5 sells. Total volume traded: €171k. Activity tracked since 11 May 2021. The latest transaction was filed on 14 June 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations18 total
26,376 shares0Common StockSEC:0001162194-23-000041:0
30,914 shares0Common StockSEC:0001162194-22-000075:0
825 shares@ US$21.510.0004% mcap9.9% of flowCommon StockSEC:0001209191-22-028707:0
50,000 shares@ US$1.330.077% mcap62.3% of flowCommon StockSEC:0001437749-22-009944:0
30,000 sharesCommon StockSEC:0001437749-22-006570:0
20,000 shares@ US$2.160.047% mcap37.7% of flowCommon StockSEC:0001437749-22-004289:0
9,840 shares0Common StockSEC:0001209191-22-006362:0
9,840 shares0Common StockSEC:0001209191-22-006362
2,063 shares@ US$24.980.0011% mcap59.0% of flowCommon StockSEC:0001209191-22-005080
2,063 shares@ US$24.980.0011% mcap26.6% of flowCommon StockSEC:0001209191-22-005080:0
7,500 shares0Common StockSEC:0001209191-22-003046
7,500 shares0Common StockSEC:0001209191-22-003046:0
4,500 shares0Common StockSEC:0001209191-21-052077
4,500 shares0Common StockSEC:0001209191-21-052077:0
10,342 shares0Common StockSEC:0001162194-21-000059:0
10,342 shares0Common StockSEC:0001162194-21-000059
2,000 shares@ US$19.140.0008% mcap18.5% of flowCommon StockSEC:0001209191-21-032314:0
2,000 shares@ US$19.1418.5% of flowCommon StockSEC:0001209191-21-032314
18 of 18 declarations
About Clague Laura
Laura Clague is associated with Travere Therapeutics, Inc.
